Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
34333 | 73 | 35.8 | 85% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | VICTORIA JOHNSON | Address | 10 | 61% | 15% | 11 |
2 | VCU PAULEY HEART | Address | 5 | 26% | 25% | 18 |
3 | VICTORIA JOHNSON S | Address | 3 | 45% | 7% | 5 |
4 | PHARMACOTHER Y OUTCOME STUDIES | Address | 2 | 67% | 3% | 2 |
5 | IL 1 TRAP | Author keyword | 1 | 50% | 1% | 1 |
6 | XOMA 052 | Author keyword | 1 | 50% | 1% | 1 |
7 | IMPERIAL MEDHEART SCI | Address | 0 | 33% | 1% | 1 |
8 | MYOCARDITIS DIAGNOSIS | Author keyword | 0 | 33% | 1% | 1 |
9 | ANGIOPLASTY CORONARY INTERVENTION | Author keyword | 0 | 25% | 1% | 1 |
10 | HIGH SUGAR DIET | Author keyword | 0 | 20% | 1% | 1 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | INTERLEUKIN 1 BLOCKADE | 1 | 50% | 3% | 2 |
2 | MRC ILA HEART | 1 | 50% | 1% | 1 |
3 | XOMA 052 | 1 | 29% | 3% | 2 |
4 | ANTAGONIST GENE POLYMORPHISM | 0 | 13% | 3% | 2 |
5 | IDIOPATHIC RECURRENT PERICARDITIS | 0 | 11% | 1% | 1 |
6 | BLOCKING INTERLEUKIN 1 | 0 | 10% | 1% | 1 |
7 | INFLAMMATORY HYPOTHESIS | 0 | 100% | 1% | 1 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
Anti-Inflammatory Strategies for Ventricular Remodeling Following ST-Segment Elevation Acute Myocardial Infarction | 2014 | 12 | 106 | 10% |
Effect of interleukin 1 beta inhibition in cardiovascular disease | 2012 | 17 | 49 | 16% |
Interleukin 1 beta A Proinflammatory Target for Preventing Atherosclerotic Heart Disease | 2014 | 2 | 57 | 11% |
The vulnerable vessel Vascular disease in diabetes mellitus | 2015 | 1 | 25 | 4% |
Actual status of antiinterleukin-1 therapies in rheumatic diseases | 2010 | 31 | 26 | 4% |
Highlights of the year in JACC 2004 | 2005 | 0 | 90 | 1% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | VICTORIA JOHNSON | 10 | 61% | 15% | 11 |
2 | VCU PAULEY HEART | 5 | 26% | 25% | 18 |
3 | VICTORIA JOHNSON S | 3 | 45% | 6.8% | 5 |
4 | PHARMACOTHER Y OUTCOME STUDIES | 2 | 67% | 2.7% | 2 |
5 | IMPERIAL MEDHEART SCI | 0 | 33% | 1.4% | 1 |
6 | NIHR LEEDS MUSCULOSKELETAL BIOMED UNIT NIHR L | 0 | 17% | 1.4% | 1 |
7 | VCU VICTORIA JOHNSON | 0 | 17% | 1.4% | 1 |
8 | SIR HENRY WELLCOME S MED | 0 | 14% | 1.4% | 1 |
9 | ABT KARDIOL ANGIOL PNEUMOL | 0 | 11% | 1.4% | 1 |
10 | CLIN SCISECT MEDNGH | 0 | 100% | 1.4% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000231632 | INFLAMMASOME//NLRP3//CASPASE 1 |
2 | 0.0000209515 | WINTERS HEART FAILURE//CARDIAC CACHEXIA//PL CACHEXIA |
3 | 0.0000202527 | HMC05//HEBEI PROV PEOPLES HOSP//DIPARTIMENTO CHIRURG GEN PARIDE STEFANINI |
4 | 0.0000131372 | IL 1RN//INTERLEUKIN 1 BETA GENE//INTERLEUKIN 1B |
5 | 0.0000115552 | VASCULAR DENDRITIC CELLS//MOL MED CEMM//OPPENHEIMER ATHEROSCLEROSIS |
6 | 0.0000096292 | C REACTIVE PROTEIN//HIGH SENSITIVITY C REACTIVE PROTEIN//CARDIOVASC DIS PREVENT |
7 | 0.0000090849 | CELLULAR REPRESSOR OF E1A STIMULATED GENES//CREG//CELLULAR REPRESSOR OF E1A STIMULATED GENES CREG |
8 | 0.0000082804 | INTERLEUKIN 1 RECEPTOR ANTAGONIST//IL 1 RECEPTOR ANTAGONIST//LYMPHOKINE RESEARCH |
9 | 0.0000077823 | APOPTOSIS REPRESSOR WITH CASPASE RECRUITMENT DOMAIN//CARDIAC OUTPUT INDEX//EXP CARDIOL |
10 | 0.0000072013 | SAN ANTONIO CARDIOVASC PROTE//CARDIAC FIBROBLASTS//MISSISSIPPI HEART |